Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LCTX | IMMX | RGNX | ||
| Company | Lineage Cell Therapeutics Inc | Immix Biopharma Inc | Regenxbio Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 1.7400 | 7.70 | 8.30 | ||
| High | 1.8500 | 8.01 | 8.83 | ||
| Low | 1.7200 | 7.44 | 8.04 | ||
| Latest | 1.8100 | 8.00 | 8.14 | ||
| Change | +0.0300 | +0.19 | -0.27 | ||
| % Change | +1.69% | +2.43% | -3.21% | ||
| Volume | 1,034,000 | 511,600 | 1,019,500 | ||
| 20-Day Average Volume | 1,211,605 | 918,440 | 1,233,375 | ||
| Previous Close | 1.7800 | 7.81 | 8.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.6770 | 6.62 | 10.21 | ||
| 20-Day Raw Stochastic | 80.00% | 91.13% | 6.32% | ||
| 20-Day Relative Strength | 55.62 | 67.97 | 32.67 | ||
| Weighted Alpha | +123.59 | +276.49 | -14.60 | ||
| Today's Opinion | 56% Buy | 100% Buy | 40% Sell | ||
| Previous Opinion | 56% Buy | 100% Buy | 24% Sell | ||
| Last Month's Opinion | 48% Buy | 56% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.47% since 02/12/26 | +7.67% since 02/12/26 | -2.51% since 02/12/26 | ||
| Low | 1.6200 on 02/17/26 | 7.16 on 02/13/26 | 7.61 on 02/19/26 | ||
| High | 1.8500 on 02/20/26 | 8.29 on 02/18/26 | 8.83 on 02/20/26 | ||
| 1-Month | |||||
| %Chg | +9.70% since 01/20/26 | +73.91% since 01/20/26 | -42.27% since 01/20/26 | ||
| Low | 1.4500 on 02/02/26 | 4.55 on 01/21/26 | 7.61 on 02/19/26 | ||
| High | 1.9000 on 02/10/26 | 8.29 on 02/18/26 | 16.19 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +8.38% since 11/20/25 | +99.00% since 11/20/25 | -25.11% since 11/20/25 | ||
| Low | 1.4500 on 02/02/26 | 3.78 on 12/03/25 | 7.61 on 02/19/26 | ||
| High | 1.9000 on 02/10/26 | 8.29 on 02/18/26 | 16.19 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +52.10% since 08/20/25 | +265.30% since 08/20/25 | +0.87% since 08/20/25 | ||
| Low | 1.1400 on 09/02/25 | 1.94 on 09/17/25 | 7.61 on 02/19/26 | ||
| High | 2.0900 on 11/03/25 | 8.29 on 02/18/26 | 16.19 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 416,894 | 423,640 | 412,071 | ||
| Shares Outstanding, K | 230,328 | 52,955 | 50,623 | ||
| Annual Sales | 9,500,000 | 0 | 83,330,000 | ||
| Annual Net Income | -18,610,000 | -21,610,000 | -227,100,000 | ||
| Last Quarter Sales | 3,680,000 | 0 | 29,730,000 | ||
| Last Quarter Net Income | -29,780,000 | -7,590,000 | -61,940,000 | ||
| 60-Month Beta | 1.80 | 0.31 | 1.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 11/06/25 | -0.24 on 11/07/25 | -1.20 on 11/06/25 | ||
| Latest Earnings Date | 03/09/26 | 03/23/26 | 03/12/26 | ||
| Most Recent Dividend | 0.080 on 12/15/03 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||